Clinical Benefit of Granulocyte-Colony Stimulating Factor (GCSF) Use During Chemoimmunotherapy Treatment for Metastatic Pancreatic Adenocarcinoma (Mpdac).
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2023)